Cargando…

Staging and imaging of small cell lung cancer

Small cell lung cancer (SCLC) has been primarily classified as limited or extensive, with limited stage confined to the primary tumor and regional lymph nodes. In the future, the TNM staging system should be integrated into the classification of SCLC. The appropriate staging work-up for patients wit...

Descripción completa

Detalles Bibliográficos
Autor principal: Kalemkerian, Gregory P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266593/
https://www.ncbi.nlm.nih.gov/pubmed/22245990
http://dx.doi.org/10.1102/1470-7330.2011.0036
_version_ 1782222195652558848
author Kalemkerian, Gregory P.
author_facet Kalemkerian, Gregory P.
author_sort Kalemkerian, Gregory P.
collection PubMed
description Small cell lung cancer (SCLC) has been primarily classified as limited or extensive, with limited stage confined to the primary tumor and regional lymph nodes. In the future, the TNM staging system should be integrated into the classification of SCLC. The appropriate staging work-up for patients with SCLC has traditionally included contrast-enhanced computed tomography (CT) scans of the chest and abdomen, bone scan, and magnetic resonance imaging or CT scan of the brain. Recent data suggest that positron emission tomography can improve both staging accuracy and treatment planning in patients with SCLC. Treatment for limited-stage SCLC consists of chemotherapy plus radiotherapy, and such therapy can cure 20–25% of patients. Extensive-stage SCLC is incurable, but chemotherapy can improve quality of life and prolong life.
format Online
Article
Text
id pubmed-3266593
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-32665932013-01-11 Staging and imaging of small cell lung cancer Kalemkerian, Gregory P. Cancer Imaging Review Small cell lung cancer (SCLC) has been primarily classified as limited or extensive, with limited stage confined to the primary tumor and regional lymph nodes. In the future, the TNM staging system should be integrated into the classification of SCLC. The appropriate staging work-up for patients with SCLC has traditionally included contrast-enhanced computed tomography (CT) scans of the chest and abdomen, bone scan, and magnetic resonance imaging or CT scan of the brain. Recent data suggest that positron emission tomography can improve both staging accuracy and treatment planning in patients with SCLC. Treatment for limited-stage SCLC consists of chemotherapy plus radiotherapy, and such therapy can cure 20–25% of patients. Extensive-stage SCLC is incurable, but chemotherapy can improve quality of life and prolong life. e-Med 2011-01-11 /pmc/articles/PMC3266593/ /pubmed/22245990 http://dx.doi.org/10.1102/1470-7330.2011.0036 Text en © 2012 International Cancer Imaging Society
spellingShingle Review
Kalemkerian, Gregory P.
Staging and imaging of small cell lung cancer
title Staging and imaging of small cell lung cancer
title_full Staging and imaging of small cell lung cancer
title_fullStr Staging and imaging of small cell lung cancer
title_full_unstemmed Staging and imaging of small cell lung cancer
title_short Staging and imaging of small cell lung cancer
title_sort staging and imaging of small cell lung cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266593/
https://www.ncbi.nlm.nih.gov/pubmed/22245990
http://dx.doi.org/10.1102/1470-7330.2011.0036
work_keys_str_mv AT kalemkeriangregoryp stagingandimagingofsmallcelllungcancer